Marksans Pharma spurts to 52-week high on share allotment to promoter
The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia
The company announced issuance of convertible warrants worth Rs 372 crore to promoter and OrbiMed Asia